A common genetic background for inflammatory bowel disease and ankylosing spondylitis: A genealogic study in Iceland

Arthritis and Rheumatism

Volumn 56, Issue 8, 2007, Pages 2633-2639

  Thjodleifsson, Bjarni ^a   Geirsson, Árni J ^a   Björnsson, Sigurdur ^a   Bjarnason, Ingvar ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FAMILIAL DISEASE; FEMALE; GENEALOGY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; ICELAND; KIN SELECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE; RISK FACTOR; ULCERATIVE COLITIS;

EPIDEMIOLOGY, MOLECULAR; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ICELAND; INFLAMMATORY BOWEL DISEASES; MALE; ODDS RATIO; PEDIGREE; SPONDYLITIS, ANKYLOSING;

EID: 34547742519     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22812     Document Type: Article

References (44)

1. Bywaters EG. Historical aspects of the aetiology of rheumatoid arthritis. Br J Rheumatol 1988;27 Suppl 2:110-5.
2. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998;42:387-91.
3. Wright V. Ankylosing spondylitis: aetiology. Proc R Soc Med 1966;59:451-3.
4. Maksymowych WP. Ankylosing spondylitis: at the interface of bone and cartilage. J Rheumatol 2000;27:2295-301.
5. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-73.
6. Orholm M, Binder V, Sorensen TI, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins: results of a nationwide study. Scand J Gastroenterol 2000;35:1075-81.
7. Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597-603.
8. Lee JC, Lennard-Jones JE. Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives. Gastroenterology 1996;111:587-96.
9. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-3.
10. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
11. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
12. Thjodleifsson B, Sigthorsson G, Cariglia N, Reynisdottir I, Gudbjartsson DF, Kristjansson K, et al. Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? Gastroenterology 2003;124:1728-37.
13. Leirisalo-Repo M, Repo H. Gut and spondyloarthropathies. Rheum Dis Clin North Am 1992;18:23-35.
14. Mielants H, Veys EM, Cuvelier C, De Vos M. Ileocolonoscopy and spondyloarthritis. Br J Rheumatol 1988;27:163-4.
15. Mielants H, Veys EM, Cuvelier C, De Vos M. Subclinical involvement of the gut in undifferentiated spondylarthropathies. Clin Exp Rheumatol 1989;7:499-504.
16. Mielants H, Veys EM, De Vos M, Cuvelier C, Goemaere S, De Clercq L, et al. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 1995;22:2266-72.
17. Vaile JH, Meddings JB, Yacyshyn BR, Russell AS, Maksymowych WP. Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives. J Rheumatol 1999;26:128-35.
18. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 1993;104:1627-32.
19. Teahon K, Smethurst P, Levi AJ, Menzies IS, Bjarnason I. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992;33:320-3.
20. Van der Paardt M, Crusius JB, de Koning MH, Murillo LS, van de Stadt RJ, Dijkmans BA, et al. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun 2003;4:77-8.
21. Laukens D, Peeters H, Marichal D, Vander Cruyssen B, Mielants H, Elewaut D, et al. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease. Ann Rheum Dis 2005;64:930-5.
22. De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989;96(2 Pt 1):339-44.
23. Porzio V, Biasi G, Corrado A, De Santi M, Vindigni C, Viti S, et al. Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis. Scand J Rheumatol 1997;26:92-8.
24. Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondylarthropathy [review]. Arthritis Rheum 2001;44:2728-36.
25. Bjarnason I, Helgason KO, Geirsson AJ, Sigthorsson G, Reynisdottir I, Gudbjartsson D, et al. Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis. Gastroenterology 2003;125:1598-605.
26. Bjornsson S. Inflammatory bowel disease in Iceland during a 30-year period, 1950-1979. Scand J Gastroenterol Suppl 1989;170:47-9.
27. Bjornsson S, Johannsson JH, Oddsson E. Inflammatory bowel disease in Iceland, 1980-89: a retrospective nationwide epidemiologic study. Scand J Gastroenterol 1998;33:71-7.
28. Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000;12:31-8.
29. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6.
30. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
31. Gulcher J, Kong A, Stefansson K. The genealogic approach to human genetics of disease. Cancer J 2001;7:61-8.
32. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65.
33. Gulcher JR, Kristjansson K, Gudbjartsson H, Stefansson K. Protection of privacy by third-party encryption in genetic research in Iceland. Eur J Hum Genet 2000;8:739-42.
34. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990;46:222-8.
35. Guo SW. Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting. Am J Hum Genet 1998;63:252-8.
36. Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, et al. Familiality of cancer in Utah. Cancer Res 1994;54:2378-85.
37. Halme L, Turunen U, Helio T, Paavola P, Walle T, Miettinen A, et al. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol 2002;37:692-8.
38. Binder V. Genetic epidemiology in inflammatory bowel disease. Dig Dis 1998;16:351-5.
39. Brophy S, Taylor G, Blake D, Calin A. The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis. J Rheumatol 2003;30:2054-8.
40. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
41. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 1988;29:990-6.
42. Loranskaia ID, Zorin SN, Gmoshinskii IV, Shirina LI, Iurkov M, Mitrofanova IP, et al. Permeability of intestinal barrier for macromolecules in patients with Crohn's disease and ulcerative colitis. Klin Med (Mosk) 1999;77:31-3. In Russian.
43. Resnick RH, Royal H, Marshall W, Barron R, Werth T. Intestinal permeability in gastrointestinal disorders: use of oral [99mTc] DTP A. Dig Dis Sci 1990;35:205-11.
44. Brown MA, Brophy S, Bradbury L, Hamersma J, Timms A, Laval S, et al. Identification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum 2003;48:2234-9.